Globus Medical (GMED) Tops Q3 EPS by 7c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports Third Quarter 2018 Results
November 8, 2018 4:15 PM ESTAUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018.
Worldwide sales were $169.2 million, an increase of 11.5% as reportedThird quarter net income was $35.2 million, an increase of 37.6%Diluted earnings per share (EPS) was $0.35 and non-GAAP diluted EPS was $0.39Non-GAAP diluted EPS increased 29.2% compared to third quarter of 2017Non-GAAP adjusted EBITDA was 34.1% of salesThe third quarter marks the fourth consecutive quarter of... More
